Categories
Search

Archive for December, 2009

BioElectronics Completes Menstrual Pain Clinical Study

Thursday, December 31st, 2009

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of economical, disposable hallucinogenic-self-governed anti-inflammatory devices, announced its clinical study on the use of Allay™ Therapy with a view the treatment of menstrual soreness and cramping (primary dysmenorrhea) pleasure conclude on May 8. BioElectronics intends to folder 510(K) premarket notification for the data of reducing menstrual agony symptoms with the U.S. Food and Medicine Charge by the stop of May.

“Participants were recruited quicker than we had initially expected, allowing us to group our data a month vanguard of schedule,” commented Barry Eppley, M.D., D.M.D., the study’s primary investigator. “There has been a huge amount of enthusiasm about our research; many more women than we needed requested participation. The study’s results will be published over the next not many weeks.”

Andrew Whelan, CEO of BioElectronics Corp., commented, “Between 60 and 70 percent of women suffer from pain during menstruation, with millions of women experiencing pain severe enough to restrict their daily activities. BioElectronics believes a multimillion dollar market exists for the treatment of primary dysmenorrhea. Our version of PEMF remedy offers strong bid fair through despite the reduction or alleviation of such vexation.”

The Allay study was conducted by Dr. Barry Eppley, of Indianapolis, Indiana and Dr. Sheena Kong, of San Francisco, California.

In the initial pilot bone up on, which was released during October of 2008, 23 female patients (ages 19 to 37) with problematic menstrual issues used the Allay Time continuously for five days following the beginning of their menstrual period. The women rated their pain over this at intervals frame using the same 1-10 pain scale that they had used during a authority over days. During the control period, the commonplace composite pain rating was 7.8 with mediocre every day composite pain ratings from hour equal to five at 8.3, 7.9, 7.4, 6.5 and 5.7, severally. During the Allay treatment sessions the normally composite pain rating was only 5.4, with average daily composite pain ratings of 5.7, 4.8, 4.3, 3.4, and 2.1. This correlates to total misery reduction on a daily point of departure of 31 percent, 39 percent, 42 percent, 48 percent and 73 percent respectively.

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Analysis, RecoveryRx™ Devices, HealFast™ Remedy (http://www.healfasttherapy.com) and Allay™ kith and kin of inexpensive, non-returnable anaesthetize-free anti-insurgent devices. These devices utilize embedded battery operated microchips to bear weeks of bailiwick treatment for solely about a dollar a day. The unparalleled delivery method, using patented technology, provides a cost shit patient friendly method to reduce soft tissue pain and swelling. ActiPatch is approved by salubrity Canada for the comfort of pain and musculoskeletal complaints. The US superintendence scoff and dope administration (FDA) has cleared the use of the consequence for reducing edema (swelling) following blepharoplasty and the European Union has approved the product as a Stratum II pulsed electromagnetic medical monogram as maintain numerous other international agencies. For more information please see http://www.BioElectronicsCorp.com.

Riskless Harbor Statement

This news release contains forward-looking statements coordinated to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies In light of simultaneous conditions, expected tomorrow developments and other factors it believes to be apropos. Existing results may differ as a result of factors over which the company has no control.

Source
BioElectronics Corporation

U.S. Adults ‘Needlessly Vulnerable’ To Vaccine-Preventable Diseases, According To New Report

Tuesday, December 29th, 2009

Fifty thousand American adults die every year from vaccine-preventable diseases. Hundreds of thousands more are hospitalized and miss incorporate because of infections that could be prevented with vaccines. Yet, most Americans continue to think of vaccines as benefiting only children, not adults.

In an effort to raise awareness about the importance of the full-grown immunization schedule, the National Foundation through despite Infectious Diseases (NFID), with fortify from the nation’s leading health organizations, has issued a Call to Action to revive heart-broken vaccination rates among adults. Most adults are not protected against vaccine-preventable diseases, leaving them vulnerable to long-term torment that could follow in a apex price label for haut monde.

To help ready the public, healthcare providers and the media, NFID launched a new complete Network location on the importance of adult vaccination at http://www.adultvaccination.com. The Web site includes momentous information on 13 adult diseases and the vaccines recommended to protect against them. The Call to Encounter also is available for download on the Web site.

“Vaccines are as crucial to our wish-term health as are screenings in requital for sure cancers. Unfortunately, multifarious adults associate vaccinations with adolescence, or assume influenza is the exclusive vaccine they need,” said William Schaffner, MD, President-Select of NFID and chairman of the Department of Preventive Medicine at Vanderbilt University School of Medicine. “Vaccines are currently ready to keep safe adults against many serious illnesses, but they are significantly beneath the waves-used, elevating the risk of ailment and even obliteration.”

NFID announced its Invite to Action and online resources at an Interactive Online Well-controlled Symposium on April 2, 2009, which provided an in-depth medical briefing on recommended adult vaccines and the power of immunity.

“Unfortunately, adult vaccines are not on patients’ radar. Increased education is needed to help confirm adults be in sympathy with the prominence of vaccination and recognize which vaccines they should net. Healthcare providers also must swear to recommending vaccination for their grown up patients,” said Susan J. Rehm, MD, NFID Medical Director and Vice Chair of the Department of Transmissible Disease at Cleveland Clinic. “Bottom contract for - it is a public form imperative to screen more adults from vaccine-preventable diseases.”

Saving Lives: Integrating Vaccines for Adults into Routine Heed

NFID’s Call to Action, “Saving Lives: Integrating Vaccines for Adults into Routine Sorrow,” was developed based on dialogue with top health organizations, including the American College of Obstetricians and Gynecologists, American College of Physicians, American Medical Affiliation, Centers for Disease Control and Prevention and Infectious Diseases Society of America. The Call to Action emphasizes the impact that vaccine-preventable diseases accept on adults, and the benefits of vaccination with a view individuals and the community at large.

The Enlist to Battle highlights barriers to immunization and presents practical strategies that can be used to recover mature vaccination rates, including:

– Increasing awareness of the adult immunization outline; communicating who should be vaccinated and when.

– Educating individuals about their implied for spreading plague among family/friends if they remain unvaccinated.

– Making mature immunization a part of routine self-possessed care; discussing vaccines with all patients and immunizing at all opportunities (well, unwell and follow-up visits).

– Prompting patients to appeal to about vaccines and prompting healthcare providers to adopt processes to safeguard resolved immunizations are up to old-fashioned.

AdultVaccination.com Provides Tools and Message through despite the Purchasers and Medical Professionals

NFID’s new adult vaccination Entanglement site (http://www.adultvaccination.com) is a comprehensive resource on adult vaccine-preventable diseases for the general collective, healthcare providers and the media. Please includes disease-specific resources and grave prevention information, including which vaccines adults should receive, and the top ten reasons to into the possession of vaccinated.

Resources for healthcare providers register tools to assist in improving mature vaccination rates, such as reminder postcards and phone scripts, patient education materials, and experience order orders payment a multifariousness of diseases and vaccines. Information payment the media includes backgrounders on full-grown vaccine-preventable diseases and downloadable graphics.

Force of Full-grown Vaccine-Preventable Diseases

Nearly 50,000 American adults disintegrate every year from vaccine-preventable diseases. Millions more oversight train, cannot heed for those who depend on them and hazard spasm their infections on to others. Up to this time, a 2008 NFID consumer investigation on adult immunization found a significant knowledge recess and lack of concern about vaccination. Fitted example, 40 percent of respondents said because they had vaccines as a child, they did not privation them again, and more than one-third (34 percent) reported a lack of concern about catching vaccine-preventable diseases.

The burden of many of age vaccine-preventable diseases in terms of cost and lives lost is high. Into example:

– Influenza kills an average of 36,000 people annually and is associated with over $10 billion in costs with a somewhat grim seasonal outbreak.

– Pertussis, with an estimated anecdote to three million cases each year, can lead to pneumonia and exposure of infants, who are at greatest risk of death from pertussis.

– Pneumococcal plague, which causes pneumonia and invasive infections, kills almost 5,000 annually.

– HPV infects more than 6 million females per year; two HPV strains included in the vaccine originator 70 percent of all cervical cancers.

– Shingles choice affect equal in three Americans in their lifetime. The accompanying Draconian vexation syndrome (post-herpetic neuralgia) may last months or years after the shingles venturesome heals.

– Hepatitis B-mutual liver disease kills encircling 5,000 Americans and costs $700 million annually.

About the National Instituting in support of Infectious Diseases

The National Foundation for Catching Diseases (NFID) is a non-profit, tax-exempt (501c3) organization founded in 1973 and dedicated to educating the known and healthcare professionals close to the causes, treatment and prevention of catching diseases.

About the Resident Basement in compensation Catching Diseases’ Adult Immunization Initiative

NFID’s adult immunization initiative is an informative program aimed at increasing awareness centre of patients, providers and the media about the part of adult vaccination in preventing harmful infectious diseases.

NFID’s adult immunization initiative is made viable through unrestricted edifying grants to NFID from GlaxoSmithKline, Merck, sanofi pasteur and Wyeth Pharmaceuticals.

Patriotic Foundation for Infectious Diseases
http://www.nfid.org

Susceptibility To Cleft Palate Revealed By Genetic Profile

Sunday, December 27th, 2009

For the first time, researchers from the University of Pittsburgh Tutor of Dental Remedy have identified a series of genetic mutations that come up to be linked to significant risk on cleft palate and other dental abnormalities. These are devastating conditions that grounds tremendous venereal isolation, and also are associated with decreased lifespan, a higher hazard of cancer and increased susceptibility to psychiatric disorders, even after surgical renew.

As reported in the September issue of Genetics in Medicine, Alexandre Vieira, DDS, Ph.D., assistant professor in the Department of Word-of-mouth Biology, University of Pittsburgh School of Dental Medicine, and colleagues unruffled and evaluated genetic cloth from the saliva and blood of more than 500 individuals in family groups with two or more siblings awkward with cleft lip or palate, and an additional 100 people from unrelated families whose samples were cast-off into general-population comparison data. The researchers analyzed 1,489 variations in DNA sequences, known as separate-nucleotide polymorphisms, in 150 genes.

“We found a group of more than a dozen gene mutations that appear to be significantly associated with cleft lip and palate, as glowingly as other dental abnormalities - predominantly at the locations for ERBB2, CDH2 and IRF6,” said Dr. Vieira, who is a pediatric dental specialist. “Here we report, for the first yet, an extensive candidate gene analysis for cleft susceptibility, a crucial step that may aside for better estimates of recurrence risk in individual families.”

Collecting the genetic data from members of extended family groups living among the 7,000 islands in the Philippines presented its own challenges in the form of typhoons and severe tropical storms, at least one major landslide and generally complex local public conditions that restricted areas to which researchers could safely travel. Field researchers were stranded for more than a week and planned in to lend a hand emergency let loose personnel following a jumbo mudslide on Southern Leyte that caused widespread wreck and loss of entity in February 2006.

“In some cases, it would be two whole days of trek by small craft, machine and foot to reach just single parentage in a faint village,” said Dr. Vieira. “It took us about three years to finish the project.”

The gene ERBB2 has been associated with hostile breast cancer, while IRF6 is linked to crystallization of the connective tissue, such as the palate. CDH2 is a gene associated with left-legal asymmetry. Other genes of interest that were identified include MSX1, PVR, PVRL and TGFA.

Associated tooth abnormalities laboured included families where people had extra teeth, or teeth that were petite or missing. Missing teeth was the most over again observed abnormality, the researchers noted.

Cleft lip and palate is a non-private birth defect, on run-of-the-mill affecting down one in 700 live births worldwide. In general, Asian populations have a higher prevalence of cleft lip and palate at with reference to one in 500 births. Aggregate Caucasians, the scold is one in 1,100, and African populations sire the lowest grade at one in 2,500 births.

“In the Philippines, affected people can be unequivocally isolated socially, miserable, alcoholic and profuse smokers with a inhuman time speaking. Access to care is very difficult,” said Dr. Vieira. “The faith is to be able to narrow down the genes that cause clefts and to screen as that jeopardy - and, in the course of time, to at all premier to gene therapy targets, although that may not happen in my lifetime.”

—————————-
Article adapted by Medical Tidings Today from original the media put out.
—————————-

The study was funded by the Nationalistic Institute of Dental and Craniofacial Research of the Native Institutes of Health.

In adding up to Dr. Vieira, other study authors are Toby G. McHenry, B.S., and Mary L. Marazita, Ph.D., University of Pittsburgh; and Sandra Daack-Hirsch, R.N., Ph.D., and Jeffrey C. Murray, M.D., University of Iowa.

Source: Michele D. Baum

University of Pittsburgh Schools of the Fettle Sciences

What Can Genetic Variation Tell Us About The Evolution Of Senescence?

Saturday, December 26th, 2009

Ageing is believed to have evolved by two genetic mechanisms; at one requires mutations that reduce survival or propagation only at late adulthood, whilst the other involves mutations that increase these traits at antique age at the expense of late-acting vigour traits.

One least popular entry in return evaluating the ancillary to influence of each process involves estimating quantitative genetic parameters for the sake age-typical of mortality or fecundity. We re-examine the population genetic theory that is used to justify these tests and generalize it to model more realistic genetic conditions.

We show that under the more general unequalled, these widely-used quantitative genetic tests are not necessarily diagnostic of which evolutionary pathways have led to senescence.

Proceedings of the Royal Society B: Biological Sciences

Proceedings B is the Magnificent Society’s flagship biological research album, dedicated to the rapid publication and broad dissemination of high-calibre research papers, reviews and comment and reply papers. The expanse of the annal is distinct and is especially strong in organismal biology.

Proceedings of the Earl Verein B: Biological Sciences

T-Cadherin Affects Blood Vessel Growth In Breast Cancer, Hormone From Fat Cells May Play A Role

Wednesday, December 23rd, 2009

Researchers at the Burnham Institute for Medical Exploration (Burnham) may obtain found a new option for targeted heart of hearts cancer therapy by showing the link between a certain protein and the forming and development of blood vessels that feed teat tumors. Like mortar between bricks in a wall, T-cadherin is a protein that helps cells extend together and collectively form tissues. Cancer cells that unbuckle their adhesive pack bonds stop producing T-cadherin, and in tumors, only the blood vessels that supply oxygen and nutrients express this protein. Now, Barbara Ranscht, Ph.D., and Robert Oshima, Ph.D., at Burnham be suffering with led a team that developed the first living model to reflect on this protein’s effect on tumor angiogenesis by creating a pull of mice that develops spontaneous mammary gland tumors in the lack of T-cadherin. Their results appeared in Cancer Research.

“Evidence of T-cadherin’s role in vascularization has been more controversial,” explains Dr. Ranscht, superior maker of the look at, which includes Drs. Lionel Hebbard and Michèle Garlatti from the Burnham Guild as equally contributing commencement authors and Drs. Robert Cardiff and Lawrence Young as collaborators from the University of California, Davis. “But our knockout model clearly shows that T-cadherin plays a role in promoting tumor vascularization, with implications for tumor expansion and savage survival.”

The tumor replica developed in Dr. Ranscht’s laboratory shows that demise of T-cadherin slows down tumor growth and improves survival compared to controls where T-cadherin is present: The non-presence of T-cadherin delays tumor growth by an average of 10 days, decreases tumor size, and apoptosis markers, indicators of cubicle suicide, are six times higher. The tumor-attitude knockouts live an average of 18.5 days longer than their wild-type counterparts, which translates into approximately 18 months of magnanimous life span.

The typical models in the study developed solid adenocarcinoma heart of hearts tumors, whereas the knockouts formed improperly-differentiated breast tumors with fewer blood vessels. When the adenocarcinoma tumors were transplanted into run-of-the-mill and T-cadherin-deficient mammary glands the knockouts were short in growing new blood vessels to the graft.

Stunting blood holder growth restricts tumors and prolongs survival - a strategy behind anti-angiogenesis cancer drugs like Avastin - so these results were degree expected, says Dr. Ranscht. “But what surprised us,” she adds, “was that even though our models survived longer, their tumor pathology worsened.” Without T-cadherin-mediated vascularization, breast cancer cells consistently metastasized to the lungs, and this did not prove in the control mice where the tumors were highly vascularized.

The reasons in place of this trend are not clear: loose connections between vascular cells may make it easier for tumor cells to break off the mark and enter the blood stream, or low blood flow and oxygen levels in the tumor environment may about laid-back radicals to build up, spurring further mutations and malignancy.

Either way, says Dr. Ranscht, “Our business provides a cautionary example that restricting tumor angiogenesis might result in more aggressive disease in the long run. Thus, anti-angiogenic therapies should be carefully evaluated, because if growth at the peerless tumor area slows but at the word-for-word frequently women bring out more aggressive, metastatic cancers, then it is vital to emerge and add treatments that prevent this.”

This study also showed instead of the first time in a living nonpareil that T-cadherin is essential also in behalf of binding adiponectin, a hormone produced by fatty tissue that is released in inversely proportional amounts to body fat. Adiponectin has a protective any way you look at it become operative against metabolic diseases including diabetes, hypertension, heart disease, and stroke; infrequently for the first time it is linked in a living model with vascular commission, a relationship that the Burnham span is still exploring. “While the link between obesity and breast cancer is complex, this study shows that in the mouse, T-cadherin sequesters much of the adiponectin and thus provides a conceptual link between embonpoint and soul cancer” notes Dr. Oshima.

This up on is supported by grants from the Resident Institutes of Condition and the Department of Defense.

About Burnham Alliance for Medical Research

Burnham Institute for Medical Inquire into uses an entrepreneurial, collaborative approach to medical research to gala the basic molecular causes of disease and give the innovative therapies of tomorrow. The Institute is organized into five research centers: a Inhabitant Cancer Society-designated Cancer Center; the Del E. Webb Center with a view Neurosciences, Aging and Reduce Cubicle Scrutinize; an Transmissible and Fiery Virus Research Center; a Diabetes and Obesity Research Center; and the Sanford Children’s Health Scrutinization Center. Thanks to the supremacy of its members members, Burnham ranks among the surpass 25 organizations worldwide (according to the Set up for the purpose Scientific Information) in the interest of its scrutinization impact and expanse the stopper four research institutes nationally for NIH supply funding. Burnham is a nonprofit, public promote corporation headquartered in La Jolla, California, with campuses in Orlando, Florida and Santa Barbara, California. Representing more information, will visit http://www.burnham.org/default.asp?contentID=1.

Source: Andrea Moser

Burnham Institute

View hallucinogenic information on Avastin.

LATITUDE Pharmaceuticals: Nanoemulsions Are A Superior Approach To Formulating Insoluble IV Drugs

Tuesday, December 22nd, 2009

LATITUDE Pharmaceuticals, Inc. (LPI), a San Diego-based drug formulation developer, reported that it is entering its fifth year of formulating a wide collection of unsatisfactorily soluble/insoluble tranquillizer compounds using its proprietary intravenous (IV) nanoemulsion technology. To date, dozens of insoluble poison compounds prepare been formulated successfully with this draw and two (docetaxel and vinorelbine) are currently at the NDA-filing stage.

LPI’s harmonious ‘ nanoemulsions incorporate FDA-approved oils and lipids in a proprietary, non-liposomal and manufacturing-friendly system to supply low cost, sturdy, filter-sterilizable and lyophilizable drug-carrying formulations.

LPI’s easy-to-administer nanoemulsions are free of toxic solubilizers such as Cremophor®, polysorbate 80, DMSO, or other essential solvents that can genesis adverse reactions. Their improved safety has been proven in benignant studies, which also showed the feeling-irritation from phlebitis-inducing drugs could be eliminated.

LPI’s nanoemulsions have been successfully engineered to look-alike the pharmacokinetic profiles of marketed drugs, enabling a impetuous 505(b)(2) regulatory pathway. They can also humiliate the neurotoxicity of cytotoxic drugs and selectively deliver drugs to constant organs.

“Our nanoemulsion stand is a proven safer and more business-like solicit to formulating insoluble drugs. We are receiving stout involved in this technology because of its success in formulating self-possessed the most insoluble young chemical entities and approved drugs,” noted Andrew X. Chen, Ph.D., President of LPI and the inventor of LPI’s nanoemulsion technology. “Drug developers can now capture the value of promising drugs that otherwise would be dissipated because of poor solubility or compromised with a less safe formulation.”

This advantageous technology is pull apart of LPI’s formulation development repertoire and is covered by a suite of pending patents. Adore LPI’s other technologies, the nanoemulsions are designed to add value to untested compounds and reformulated, off-obvious drugs by providing additional egghead property protection and other value-adding enhancements.

Beginning
LATITUDE Pharmaceuticals, Inc

ZOLL Medical cleared to market defibrillator with WiFi option

Sunday, December 20th, 2009

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Foodstuffs and Benumb Administration (FDA) to market and sell the ZOLL R Series Encypher-Ready clinical defibrillator with a WiFi recourse that allows wireless communication between the defibrillator and standard asylum networks to help ensure jus civile ‘civil law’-expertness and download philosophical data.

Based on standard 802.11b WiFi technology, R Series defibrillators equipped with WiFi automatically send an alert when their state of readiness is compromised. Early notification maximizes patient safety by letting the clinician intervene before the defibrillator is needed for a code.


While defibrillators rarely fail, their readiness can be compromised if someone forgets to plug it in, a cable is missing, or the electrodes are old and dried out. With WiFi, when the state of readiness is compromised, a notification identifies the contributing factors and code readiness can be restored with unmatched efficiency by troubleshooting from any PC on the hospital network.


For downloading patient data, the Defibrillator Summary is an important part of the code, and the R Series WiFi capability simplifies merging the Summary Report with event documentation. At the end of the code, the summary report can be transmitted over a standard wireless network to a server hosting the CodeNet ® system, where it is merged and time-synchronized with the Event Report documented on CodeNet Writer.


“Since defibrillators are widely distributed throughout hospitals, and their use is both infrequent and extremely critical, ZOLL’s technology helps ensure code readiness when they are needed for a code,â€? said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL. “Introducing technology that helps clinicians save more lives is what ZOLL is about.â€?


ZOLL R Series: Simple, Smart, Ready


The R Series is a Code-Ready device that is simple, smart, and ready to use. It offers a OneStep â„¢ system to simplify and speed up deployment of pacing and defibrillation therapy. It also offers smart tools to help clinicians improve CPR performance, which is important since more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment is high-quality CPR with minimal interruptions.


The R Series can also verify the condition and expiration date of the electrode set. All of this testing occurs without disconnecting electrodes or paddles, or requiring additional equipment to test shock delivery. The system provides a printed or electronic log to alert hospital personnel of any concerns in advance of a code. A simple green checkmark indicates that the R Series is fully ready for use.


CodeNet: Efficient Patient Data Capture


CodeNet is the first software system that allows hospital teams to better document, manage, and review cardiac arrest event and resuscitation information. It brings new improvements and efficiencies in data capture, event time synchronization, and case and aggregate reporting. It is the only system that time stamps logged events and synchronizes these times with defibrillator data, providing clinicians with a complete and accurate timeline of an entire cardiac arrest event.


With a simple click of a mouse, CodeNet system users can submit records to the American Heart Association’s NRCPR (National Registry of Cardiopulmonary Resuscitation).


About ZOLL Medical Corporation


ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help ® and See-Thru CPR ® , that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.


ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com.


Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-lookingâ€? statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factorsâ€? in the Company’s Annual Report on Form 10-K filed with the SEC on December 8, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.


Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, CodeNet, Code-Ready, R Series, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. One-Step is a trademark of ZOLL Medical Corporation. All product names are the property of their respective owners.


http://www.zoll.com

New method studies living bacteria cells

Friday, December 18th, 2009

Researchers at the U.S. Bank on of Energy’s Argonne National Laboratory have ground a new way to weigh individual
living bacteria cells and analyze their chemistry.

In research published today in Science, the scientists second-hand exuberant-animation X-beam fluorescence measurements for the purpose mapping and
chemical analyses of single free-floating, or planktonic, and surface-adhered, or biofilm, cells of Pseudomonas fluorescens.
The results showed differences between the planktonic and adhered cells in morphology, elemental composition and sensitivity
to hexavalent chromium, a heavy-metal contaminant and a known carcinogen. The biofilm cells were more tolerant of the
contaminant, while it damaged or killed the planktonic cells.

In supplement to determining the chemical differences between the cells, the suss out d evolve also pioneers a potentially revolutionist chic
technique for investigating microbiological systems in natural subsurface environments. This study advanced the development
of anticyclone-energy X-beam microprobes and methods for using the microprobes to inquire into single bacterial cells. The new
capabilities set the tier in spite of time to come studies defining mineral-metal-microbe interactions in contaminated environments.

“This mode also should be in a beeline right to investigations of microbial processes in different subsurface
environments and to studies of a variety of astrobiology topics, such as detection of heretofore or present life in samples
returned from Mars, or determinations of the origins of life,” said lead author Ken Kemner of Argonne’s Environmental
Research Division.

No previously available techniques had the spatial accuracy needed to analyze solitary bacterial cells noninvasively and
nondestructively. Recent developments at the Advanced Photon Source (APS) at Argonne enabled the production of X-flicker beams
insignificant enough to probe pick bacterial cells, which are typically one-hundredth the diameter of a human hair. The APS
provides the nation’s most brilliant X-rays looking for investigate.

In these experiments, scientists exposed both planktonic and biofilm cells to raised concentrations of hexavalent chromium.
The researchers then adapted to X-ray fluorescence microscopy to measure the concentrations of elements in specific cells previously
and after exposure to the heavy metal. The results indicated that X-ray fluorescence opinion had distinguished living
bacterial cells from full cells for the ahead time. The analysis also showed that a bone-like mineral deposit had formed
approximately the surface of the adhered cells. This put away made the adhered cells much more tolerant than planktonic cells to
elevated levels of the contaminant.

Next, the researchers used the stick-to-it-iveness tunability of the APS X-ray beamline for spectroscopy experiments on the bacterial
systems. These experiments showed that the ostensibly adherence of the biofilm cells promoted tolerance to the chromium and
reduced its toxicity floor.

Conclusively, when the cells made the modification from the planktonic state to the biofilm state, the scientists observed changes
in the concentrations of diverse transition metals required for bacterial person. These results call to mind that X-ray fluorescence
analysis might be worthwhile for determining whether a bacterial cell is living or dead.

“No other system has been capable of determining the metabolic say of a singular hydrated room and the chemical speciation
of metals on, in or close-fisted a bacterial cell,” Kemner said. “The achievements of this study have the potential to revolutionize
the way scientists investigate mineral-metal-microbe systems.”

Other authors on the report, in beyond to Kemner are Shelly D. Kelly, Edward J. O’Loughlin and Deirdre Sholto-Douglas
(Environmental Research Division, Argonne); Barry Lai, Joerg Maser and Zhonghou Cai (Experimental Facilities Upset,
Argonne); Splotch Schneegurt (Wichita State University); Charles F. Kulpa, Jr. (University of Notre Dame); and Kenneth H.
Nealson (University of Southern California).

Funding for this project came from the Natural and Accelerated Bioremediation program of the U.S. Unit of Energy’s
Mediation of Biological and Environmental Research.

The nation’s senior public laboratory, Argonne Public Laboratory conducts primary and applied scientific research across a
extreme spectrum of disciplines, ranging from high-vivacity physics to climatology and biotechnology. Since 1990, Argonne has
worked with more than 600 companies and numerous federal agencies and other organizations to help advance America’s
scientific leadership and prepare the nation for the future. Argonne is operated by the University of Chicago for the U.S.
Department of Energy’s Office of Science.

For more information, please in Donna Jones Pelkie (630/252-5501 or media@anl.gov) at Argonne.

Contact: Donna Jones Pelkie
djpelkie@anl.gov
630-252-5501
DOE/Argonne Patriotic Laboratory

Rescue Remedy Is An Effective All-Natural Stress, Anxiety Reliever, New Study Shows

Tuesday, December 15th, 2009

A scarcely published thorough scrutiny conducted by researchers at the University of Miami Educational institution of Nursing in conjunction with The Sirkin Original Living Center (SCLC) has found that Rescue Remedy™, an all-actual remedy created from flower essences, is an real across-the-disc stress reliever with a comparable effect to traditional pharmaceutical drugs yet without any of the known adverse side effects, including addiction.

Let loose Remedy, manufactured by Nelsons, contains five flower essences: Rock Rose to alleviate mad dog and panic, Impatiens to mollify irritation and impatience, Clematis to combat inattentiveness, Star of Bethlehem to steer shock, and Cherry Plum to calm irrational thoughts. Available in a useful spray bottle or in drop visualize, it helps to provide better emotional ponder and fast, convenient relief from quotidian put under strain.

“The result of this independent study is not however welcome communique for those of us who come into contact with stressful situations every day, but particularly quest of the 40 million Americans who suffer from physician-diagnosed anxiety,” said Ronald Stram, MD, who regularly prescribes Let loose Drug to his upset and stressed patients. “Stress compromises your ability to dissension off disease and infection. It can even rewire the mastermind, making you more vulnerable to unimaginative pressures and problems.”

—————————-
Article adapted by Medical News Today from primordial press release.
—————————-

Rescue™ Remedy has been a popular force reliever since 1930 but until now had not been quite investigated scientifically. This study specifically examined the artefact as far as something the reduction of acute situational disturb. A double-dim-witted clinical trial comparing a standard dosage of Rescue Remedy against a placebo of same appearance was conducted in a sample of 111 individuals grey 18 to 49. The Spielberger State-Trait Appetite Inventory (STAI) - a standard means to evaluate anxiety - was administered before and after the manoeuvre of Liberate Remedy or placebo. The results suggest that Saving Remedy may be effective in reducing exhilarated levels of situational disquiet. The results were perfectly published in the latest print run of Complementary Healthiness Practice Assessment.

Consumers can almost certainly purchase Rescue Remedy finished the table, without a remedy. Please visit http://www.rescueremedy.com/ for more info.

About Nelsons USA

Nelsons USA of Wilmington, Massachusetts is large of the Nelsons group based in London. Founded in 1860, Nelsons is a extraction-owned organization with a long-standing commitment to supplying intoxication excellence, crap consonant medicines. Their products are sold all over the world and include Rescue™ Correct, Bach™ Original Flower Remedies, Nelsons Arnicare™, Nelsons Teetha™, and Nelsons™ Homeopathy. More data is handy at http://www.rescueremedy.com/.

Telephone: Christen Graham

Nelsons, Inc.

Pamper yourself -”have the essence of being in cloud 9″

Saturday, December 12th, 2009

Many people in the excellent are not happy with their look and they are everlastingly hoping to advance the perfect look of their importune. So far there was no particular to correct their shapelessness or bad look but it has modern made possible with a revolutionary invention of medical proficiency widely known as cosmetic makeover. It has an know-how to censure any external appearing defect and to offer you the most desired, normal, youthful and refreshing look. The theorize correcting treatment has a Brobdingnagian array of diverse types of earthly correction treatments like liposuction cosmetic surgery, knowledge cosmetic surgery, crust cancer reconstructive surgery, facial cosmetic surgery, facelift, executive mini facelift, chin and cheek implants, ear reparation, lip augmentation, breast implant, unqualified cosmetic makeover, laser hull rejuvenation, reshaping of nose, ear and discrimination brows etc. Now it is then to mollycoddle you and enjoy the refreshing look with the resist of cosmetic makeover. The cosmetic makeover has generated scads misconceptions centre of the people and Cosmeticmakeover is here to cultivate awareness develop into the people at hand its tariff effective benefits destined for the permanent correction of any physical shapelessness. To educate the people all round the facts, they make available complete cosmetic surgery information either themselves or you can get that while logging in on their website. Besides they also put on the market the complete estimate of the treatment and its duration. Apart from being cost effective it does not put into effect any longer to pull through from the treatment and extend you naturally youthful desired look. Admit us look over some of the most common and non-professional cosmetic surgery treatments. Rightful to the uncontrolled and careless habits of edible intake, many people develop the huge amount of unwanted elements of cellulite into their bodies. The body becomes battered and it creates out-and-out discomfort into their pattern frequent moments. They have found cursing themselves owed to their tremendous mortal tome and trying every achievable way to absorb the unprecedented give form to again but it is not that easy if they extend their eating habits the very style. Orderly concern and diet would take quite long to offering them their original structure. Most of them are greatly disappointed in life with the great discomfort. Liposuction is one of the cosmetic surgeries that helps in removing all the unwanted cellulite from the hull and helps to contain the youthful shape of the majority again with seamless cosmetic makeover. The liposuction cosmetic surgery just take couple of days to regain the youthful and like a breath of fresh air look again and the stitching marks would be vanished gradually. Another frequent use of cosmetic surgery is heart of hearts implantation using various synthetic import, everywhere accepted among the female celebrities for the swell-headedness determination and to claim their figure and physical appeal.


Archive